PAPILLARY RENAL CELL CARCINOMA
Clinical trials for PAPILLARY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PAPILLARY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Looking back at cancer drugs: do they work in the real world?
Disease control Recruiting nowThis study is looking back at the medical records of 150 Chinese adults with a specific type of advanced kidney cancer. The goal is to see how well two existing drugs, sunitinib and sorafenib, worked to control the cancer and keep it from getting worse when used as a first treatm…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Three-Pronged attack on tough kidney cancers
Disease control Recruiting nowThis study is testing a combination of three drugs—bevacizumab, erlotinib, and atezolizumab—to see if they can control or shrink advanced kidney cancers linked to a hereditary condition (HLRCC) or a specific type called papillary renal cell cancer. The trial aims to enroll 65 pat…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
Scientists track Cancer's hidden food supply
Knowledge-focused Recruiting nowThis study aims to understand how kidney and bladder cancers use different nutrients from the blood to grow and survive. Researchers will study tissue samples from 600 patients who are already scheduled for surgery or biopsy for their cancer. By tracking specially labeled nutrien…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC